Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-020261
Filing Date
2025-07-24
Accepted
2025-07-24 19:30:27
Documents
1
Period of Report
2025-07-22

Document Format Files

Seq Description Document Type Size
1 form4-07242025_110724.html 4  
1 form4-07242025_110724.xml 4 4238
  Complete submission text file 0001415889-25-020261.txt   5689
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Issuer) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EXICURE, INC. 8045 LAMON AVENUE, SUITE 410 SKOKIE IL 60077
Business Address
Muralidhar Bali (Reporting) CIK: 0001784138 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39594 | Film No.: 251148196